LEADER 00000cam a2200793 i 4500 
001    ocm44964665  
003    OCoLC 
005    20160527041316.2 
006    m     o  d         
007    cr cn||||||||| 
008    140806s1985    dcua    obt   001 0 eng   
016 7  101641348|2DNLM 
019    70772455|a326717292|a614598089|a647356011|a666944450
       |a722244607|a728013881 
020    9780309035446 
020    0309035449 
020    0585144915 
020    9780585144917 
035    (OCoLC)44964665|z(OCoLC)70772455|z(OCoLC)326717292
       |z(OCoLC)614598089|z(OCoLC)647356011|z(OCoLC)666944450
       |z(OCoLC)722244607|z(OCoLC)728013881 
040    DNLM|beng|erda|epn|cNLM|dN$T|dYDXCP|dCOF|dMUX|dOCLCF
       |dNLGGC|dIDEBK|dINU|dDKDLA|dADU|dE7B|dFVL|dUV0|dOCLCO
       |dOCLCQ|dOCLCO 
042    pcc 
043    n-us--- 
049    RIDW 
050  4 QR189|b.V253 1985eb 
070    RM281.V33 
072  0 X380 
072  7 MED|x037000|2bisacsh 
072  7 MED|x028000|2bisacsh 
082 04 614.4/7/0973|220 
090    QR189|b.V253 1985eb 
245 00 Vaccine supply and innovation /|cDivision of Health 
       Promotion and Disease Prevention, Institute of Medicine. 
264  1 Washington, D.C. :|bNational Academy Press,|c1985. 
300    1 online resource (1 PDF file (xii, 210 pages)) :
       |billustrations. 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
340    |gpolychrome|2rdacc 
347    text file|2rdaft 
490 1  Publication IOM ;|v85-02 
500    Title from PDF title page. 
504    Includes bibliographical references and index. 
520 3  The United States is facing a vaccine shortage that may 
       threaten public health. This book examines vaccine 
       research and development, production and supply, and 
       utilization and offers recommendations aimed at ensuring 
       vaccine supply and promoting innovation. In addition, this
       comprehensive volume provides information on the adverse 
       reactions associated with the range of vaccines used in 
       the United States and contains the most thorough analysis 
       ever published on the state of the law regarding vaccine-
       related injury and compensation for vaccine injury. 
536    The study was supported under contracts with the Food and 
       Drug Administration (223-83-1109), the Department of the 
       Army (DAMD17-83-G-9558), and the Centers for Disease 
       Control (200-83-0609), and grants from Lederle 
       Laboratories, the Mericux Institute, Inc., and Merck Sharp
       & Dohme. Additional support was provided by the National 
       Research Council (NRC) Fund, a pool of private, 
       discretionary, nonfederal funds that is used to support a 
       program of Academy-initiated studies of national issues in
       which science and technology figure significantly. The NRC
       Fund consists of contributions from a consortium of 
       private foundations including the Carnegie Corporation of 
       New York, the Charles E. Culpeper Foundation, the William 
       and Flora Hewlett Foundation, the John D. and Catherine T.
       MacArthur Foundation, the Andrew W. Mellon Foundation, the
       Rockefeller Foundation, and the Alfred P. Sloan 
       Foundation; the Academy Industry Program, which seeks 
       annual contributions from companies that are concerned 
       with the health of U.S. science and technology and with 
       public policy issues with technological content; and the 
       National Academy of Sciences and the National Academy of 
       Engineering endowments. 
588 0  Version viewed October 14, 2014. 
590    eBooks on EBSCOhost|bEBSCO eBook Subscription Academic 
       Collection - North America 
650  0 Vaccines|0https://id.loc.gov/authorities/subjects/
       sh85141718|xGovernment policy|0https://id.loc.gov/
       authorities/subjects/sh99005269|zUnited States.|0https://
       id.loc.gov/authorities/names/n78095330-781 
650  0 Vaccines|0https://id.loc.gov/authorities/subjects/
       sh85141718|xTechnological innovations.|0https://id.loc.gov
       /authorities/subjects/sh2001009095 
650  7 Vaccines|xGovernment policy.|2fast|0https://
       id.worldcat.org/fast/1163579 
650  7 Vaccines.|2fast|0https://id.worldcat.org/fast/1163573 
650  7 Vaccines|xTechnological innovations.|2fast|0https://
       id.worldcat.org/fast/1163589 
650 12 Vaccines|xsupply & distribution.|0https://id.nlm.nih.gov/
       mesh/D014612Q000600 
651  2 United States.|0https://id.nlm.nih.gov/mesh/D014481 
650 22 Vaccination|xtrends.|0https://id.nlm.nih.gov/mesh/
       D014611Q000639 
650 22 Vaccination|xadverse effects.|0https://id.nlm.nih.gov/mesh
       /D014611Q000009 
650 22 Health Policy.|0https://id.nlm.nih.gov/mesh/D006291 
651  7 United States.|2fast|0https://id.worldcat.org/fast/1204155
655  4 Electronic books. 
655  7 Technical reports.|2lcgft|0https://id.loc.gov/authorities/
       genreForms/gf2015026093 
655  7 Technical reports.|2fast|0https://id.worldcat.org/fast/
       1941336 
700 1  Osborn, June E.,|d1937-|0https://id.loc.gov/authorities/
       names/n89102362|5DNLM,|edonor. 
710 2  Institute of Medicine (U.S.).|bDivision of Health 
       Promotion and Disease Prevention,|0https://id.loc.gov/
       authorities/names/n80156868|eauthor,|eissuing body. 
776 08 |iPrint version:|tVaccine supply and innovation.
       |dWashington, D.C. : National Academy Press, 1985
       |z0309035449|w(DLC)   85060772|w(OCoLC)12642659 
830  0 IOM publication ;|0https://id.loc.gov/authorities/names/
       n42031273|v85-02. 
856 40 |uhttps://rider.idm.oclc.org/login?url=http://
       search.ebscohost.com/login.aspx?direct=true&scope=site&
       db=nlebk&AN=14728|zOnline eBook. Access restricted to 
       current Rider University students, faculty, and staff. 
856 42 |3Instructions for reading/downloading this eBook|uhttp://
       guides.rider.edu/ebooks/ebsco 
901    MARCIVE 20231220 
948    |d20160615|cEBSCO|tebscoebooksacademic|lridw 
994    92|bRID